March 3, 2022 | Emilia Molimpakis, Healthcare transformation, Impetus Digital, Natalie Yeadon, Thymia, artificial intelligence, digital health, gamification, health assessment, mental health, neuropsychology
Dr. Emilia Molimpakis, CEO & Co-founder of Thymia, shares how their platform uses video games based on neuropsychology, alongside analyses of facial microexpressions and speech, to quickly, accurately, and objectively assess and monitor mental health conditions such as depression.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Jim Havelka, Founder & CEO of InformAI, discusses how AI can be used to improve medical diagnoses, patient treatment plans, outcome predictions, hospital risk mitigation, and operational efficiencies. He also…
Why virtual advisory boards should be part of every brand’s toolbox in the post-COVID new normal.
Dr. Javier Mendoza, Gastroenterologist and Digital Health Expert, explores digital health in medicine and clinical research, natural language processing, the ethics surrounding AI, and his experience as a medical doctor…
Dr. Sabita Sankar, VP of Business Development at HUMA.AI, discusses “human-centric AI” and how to automate healthcare through human language, with special focus on the applications for Medical Affairs, Clinical,…
As I wrote about earlier this year, it is clear that the climate crisis is no longer something for future generations to worry about, it’s already here and requires our urgent…
Bree Bush, Vice President, Chief Data Officer at GE Healthcare, dives into simulation modeling and advanced analytical tools to optimize inpatient, procedural, and clinic capacity; the concept of “real-time healthcare”;…
Laurence Pearce, CEO & Founder of Xim Ltd, creators of Lifelight®, discusses the need for personal health monitoring; traditional issues associated with population health screening; AI, machine learning, and computer…
Mike Cook, CEO of IDENTOS, shares how his company is making digital trust and privacy accessible for patients, healthcare providers, payers, organizations, and connected devices. He also discusses “smart cities”…
Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing…
How a Pharma team hosted daily MSL “eHuddles” during ASCO 2021 plus a post-congress debrief session using our asynchronous platform.
